Pain Improvement in Parkinson's Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study.

Diego Santos GarcíaRosa Yáñez BañaCarmen Labandeira GuerraMaria Icíar Cimas HernandoIria CaboJose Manuel Paz GonzálezMaria Gema Alonso LosadaMaria José Gonzalez PalmásCarlos Cores Bartolomé Cristina Martínez Miró

Published in: Journal of personalized medicine (2021)

Safinamide is well tolerated and improves pain in PD patients at 6 months. Future studies are necessary to analyze the possible beneficial effect of safinamide on pain in PD patients.

Keyphrases

chronic pain
pain management
neuropathic pain
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes